Aarti Drugs Limited announced the incorporation of its step-down subsidiary, Tripharma Chile SpA, in Chile. This new entity is a wholly-owned subsidiary of Pinnacle Chile SpA, which is itself a subsidiary of Aarti Drugs Limited. The incorporation was processed on February 27, 2026, with communication to company officials on March 2, 2026. Tripharma Chile SpA is established to market formulation drugs and participate in tender and private markets within Chile. Its business aligns with that of its holding companies. The initial share capital contribution is Chilean Peso 10,00,000 (approximately ₹94,000), representing 10,00,000 shares, with Pinnacle Chile SpA holding 100% of the share capital. No governmental or regulatory approvals were required for its incorporation, and the consideration was in cash.
